Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sangeeta Kashyap

Showing results (1-10 of 29) with videos related to

Pageof 3
Sort By:
Cleveland Clinic Journal of Medicine|December 3, 2021
In Reply: Antiobesity drug therapyYael Mauer, Marcie Parker, Sangeeta Kashyap
Cleveland Clinic Journal of Medicine|December 3, 2021
In ReplyYael Mauer, Marcie Parker, Sangeeta Kashyap
Current Cardiology Reports|June 22, 2018
Cardiovascular and Renal Outcomes of Newer Anti-Diabetic Medications in High-Risk PatientsLima Lawrence, Venu Menon, Sangeeta Kashyap
The Journal of Clinical Endocrinology and Metabolism|September 20, 2021
Bariatric Surgery: It's Not Just Incretins!Rafael Ferraz-Bannitz, Sangeeta Kashyap, Mary Elizabeth Patti
The Journal of Clinical Endocrinology and Metabolism|November 28, 2025
Approach to the Patient: Clinical Outcomes and Interim Strategies Following Discontinuation of Incretin AgonistsSarah R Barenbaum, Mohini Aras, Sangeeta Kashyap, et al.
Lipids in Health and Disease|August 29, 2016
The therapeutic efficacy of intensive medical therapy in ameliorating high-density lipoprotein dysfunction in subjects with type two diabetesSangeeta Kashyap, Karim Kheniser, Ling Li, et al.
Lipids in Health and Disease|November 11, 2016
Erratum to: The therapeutic efficacy of intensive medical therapy in ameliorating high-density lipoprotein dysfunction in subjects with type two diabetesSangeeta Kashyap, Karim Kheniser, Ling Li, et al.
American Journal of Physiology. Endocrinology and Metabolism|February 15, 2007
Effects on insulin secretion and insulin action of a 48-h reduction of plasma free fatty acids with acipimox in nondiabetic subjects genetically predisposed to type 2 diabetesKenneth Cusi, Sangeeta Kashyap, Amalia Gastaldelli, et al.
The Journal of Clinical Endocrinology and Metabolism|September 25, 2024
Approach to the Patient: Normocalcemic Primary HyperparathyroidismYi Liu, Naina Sinha Gregory, Panagiota Andreopoulou, et al.
The Journal of Clinical Endocrinology and Metabolism|September 10, 2004
Sustained reduction in plasma free fatty acid concentration improves insulin action without altering plasma adipocytokine levels in subjects with strong family history of type 2 diabetesMandeep Bajaj, Swangjit Suraamornkul, Sangeeta Kashyap, et al.
Pageof 3

Showing results (1-10 of 29) with videos related to

Sort By:
Pageof 3
Cleveland Clinic Journal of Medicine|December 3, 2021
In Reply: Antiobesity drug therapyYael Mauer, Marcie Parker, Sangeeta Kashyap
Cleveland Clinic Journal of Medicine|December 3, 2021
In ReplyYael Mauer, Marcie Parker, Sangeeta Kashyap
Current Cardiology Reports|June 22, 2018
Cardiovascular and Renal Outcomes of Newer Anti-Diabetic Medications in High-Risk PatientsLima Lawrence, Venu Menon, Sangeeta Kashyap
The Journal of Clinical Endocrinology and Metabolism|September 20, 2021
Bariatric Surgery: It's Not Just Incretins!Rafael Ferraz-Bannitz, Sangeeta Kashyap, Mary Elizabeth Patti
The Journal of Clinical Endocrinology and Metabolism|November 28, 2025
Approach to the Patient: Clinical Outcomes and Interim Strategies Following Discontinuation of Incretin AgonistsSarah R Barenbaum, Mohini Aras, Sangeeta Kashyap, et al.
Lipids in Health and Disease|August 29, 2016
The therapeutic efficacy of intensive medical therapy in ameliorating high-density lipoprotein dysfunction in subjects with type two diabetesSangeeta Kashyap, Karim Kheniser, Ling Li, et al.
Lipids in Health and Disease|November 11, 2016
Erratum to: The therapeutic efficacy of intensive medical therapy in ameliorating high-density lipoprotein dysfunction in subjects with type two diabetesSangeeta Kashyap, Karim Kheniser, Ling Li, et al.
American Journal of Physiology. Endocrinology and Metabolism|February 15, 2007
Effects on insulin secretion and insulin action of a 48-h reduction of plasma free fatty acids with acipimox in nondiabetic subjects genetically predisposed to type 2 diabetesKenneth Cusi, Sangeeta Kashyap, Amalia Gastaldelli, et al.
The Journal of Clinical Endocrinology and Metabolism|September 25, 2024
Approach to the Patient: Normocalcemic Primary HyperparathyroidismYi Liu, Naina Sinha Gregory, Panagiota Andreopoulou, et al.
The Journal of Clinical Endocrinology and Metabolism|September 10, 2004
Sustained reduction in plasma free fatty acid concentration improves insulin action without altering plasma adipocytokine levels in subjects with strong family history of type 2 diabetesMandeep Bajaj, Swangjit Suraamornkul, Sangeeta Kashyap, et al.
Pageof 3